StudyID,StudyName,Phase,TherapeuticArea,StartDate,EndDate,PlannedEnrollment,Status
ST001,Diabetes Drug Trial,Phase III,Endocrinology,2023-01-01,2024-06-30,5000,Ongoing
ST002,Oncology Study,Phase II,Oncology,2022-05-01,2023-12-31,3000,Completed
